Feng Zhang, one of the pioneers of CRISPR technology, has been announced as the 2017 recipient of the $500,000 Lemelson-MIT Prize, which honours outstanding inventors.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
5 October 2016 Florence Wambugu and Feng Zhang were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Wambugu and Zhang were featured in the business and innovation section, as LSIPR reports.
18 February 2016 The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF.
18 February 2016 The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF.
5 October 2016 Florence Wambugu and Feng Zhang were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Wambugu and Zhang were featured in the business and innovation section, as LSIPR reports.
18 February 2016 The IP landscape in Europe for the CRISPR gene-editing technology is very murky, making it difficult for potential licensees, says Catherine Coombes of HGF.
5 October 2016 Florence Wambugu and Feng Zhang were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Wambugu and Zhang were featured in the business and innovation section, as LSIPR reports.